The aim of this study is to evaluate the efficacy of doxycycline in relapsed Cutaneous T-cell Lymphomas (CTCL). The primary objective is to determine the overall response rate of doxycycline monotherapy in patients with relapsed CTCL.
This study looks at the efficacy of Doxycycline for the treatment of Cutaneous T-cell Lymphomas.